Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature Review

Conclusions include the following: MG in HIV-infected patients should be managed similarly to individuals without HIV infection; half develop moderate–severe MG; MG symptoms may worsen within 6 months of antiretroviral initiation; safety monitoring must include plasma HIV viral load estimation. Isoniazid prophylaxis may not be indicated in all cases.
Source: Frontiers in Neurology - Category: Neurology Source Type: research